{"id":1581,"date":"2023-03-11T11:18:18","date_gmt":"2023-03-11T11:18:18","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=1581"},"modified":"2023-03-11T11:18:18","modified_gmt":"2023-03-11T11:18:18","slug":"volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/","title":{"rendered":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/logo-61.jpg\" alt=\"Logo of Volastra\" class=\"wp-image-1584\" width=\"311\" height=\"105\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/logo-61.jpg 311w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/logo-61-300x101.jpg 300w\" sizes=\"(max-width: 311px) 100vw, 311px\" \/><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.volastratx.com\/\">Volastra Therapeutics<\/a> founded by <a href=\"https:\/\/www.linkedin.com\/in\/charleshugh-jones\/\">Charles Hugh-Jones<\/a>, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of chromosomal instability (CIN) to create innovative cancer therapies. With a recent Series A funding round of $60 million and a team of world-class investors including <a href=\"https:\/\/www.lilly.com\/\">Eli Lilly and Company<\/a>, <a href=\"https:\/\/www.archventure.com\/\">ARCH Venture Partners<\/a>, <a href=\"https:\/\/polarispartners.com\/\">Polaris Partners<\/a>, <a href=\"https:\/\/www.cataliocapital.com\/\">Catalio Capital Management<\/a>, <a href=\"https:\/\/droiaventures.com\/\">Droia Ventures<\/a>, and <a href=\"https:\/\/vidaventures.com\/\">Vida Ventures LLC<\/a>, Volastra is poised to change the game in the fight against cancer. Their proprietary CINtech platform, which leverages a deep understanding of CIN and its biological consequences, enables them to identify relevant targets more quickly, create first-in-class drugs, and select the best patients for their therapies.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"637\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-18-1024x637.jpg\" alt=\"Team at Logo of Volastra\" class=\"wp-image-1585\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-18-1024x637.jpg 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-18-300x187.jpg 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-18-768x478.jpg 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-18.jpg 1290w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>With a multi-pronged therapeutic strategy that includes synthetic lethality and immune activation, Volastra is working to stop cancer in its tracks. Their approach represents a major shift in biotech research, with a focus on targeting CIN itself rather than the genetic mutations that result from it. Volastra is poised to revolutionize how cancer is treated, and their groundbreaking work is sure to be a game-changer in the biotechnology industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of chromosomal instability (CIN) to create innovative cancer therapies. With a recent Series A funding round of $60 million and a team of world-class investors including Eli Lilly and Company, ARCH Venture Partners, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1586,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-11T11:18:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-15.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1833\" \/>\n\t<meta property=\"og:image:height\" content=\"846\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fasihsheikh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fasihsheikh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\"},\"author\":{\"name\":\"fasihsheikh\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\"},\"headline\":\"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million\",\"datePublished\":\"2023-03-11T11:18:18+00:00\",\"dateModified\":\"2023-03-11T11:18:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\"},\"wordCount\":201,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\",\"name\":\"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-11T11:18:18+00:00\",\"dateModified\":\"2023-03-11T11:18:18+00:00\",\"description\":\"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\",\"name\":\"fasihsheikh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"caption\":\"fasihsheikh\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News","description":"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/","og_locale":"en_US","og_type":"article","og_title":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News","og_description":"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of","og_url":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-11T11:18:18+00:00","og_image":[{"width":1833,"height":846,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-15.jpg","type":"image\/jpeg"}],"author":"fasihsheikh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fasihsheikh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/"},"author":{"name":"fasihsheikh","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8"},"headline":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million","datePublished":"2023-03-11T11:18:18+00:00","dateModified":"2023-03-11T11:18:18+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/"},"wordCount":201,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/","url":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/","name":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-11T11:18:18+00:00","dateModified":"2023-03-11T11:18:18+00:00","description":"Volastra Therapeutics founded by Charles Hugh-Jones, is at the forefront of a new wave of biotechnology startups, focused on harnessing the power of","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/volastra-therapeutics-is-at-the-forefront-of-a-new-wave-of-biotechnology-with-a-recent-series-a-funding-round-of-60-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Volastra Therapeutics is at the forefront of a new wave of biotechnology, with a recent Series A funding round of $60 million"}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8","name":"fasihsheikh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","caption":"fasihsheikh"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1581"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=1581"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1581\/revisions"}],"predecessor-version":[{"id":1587,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1581\/revisions\/1587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/1586"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=1581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=1581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=1581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}